Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

U.S. Managed Healthcare Industry Analysis

UpdatedNov 14, 2025
DataAggregated Company Financials
Companies11
  • 7D-0.6%
  • 3M3.1%
  • 1Y-39.5%
  • YTDn/a

Over the last 7 days, the Managed Healthcare industry has remained flat, although notably Elevance Health gained 7.3%. As for the longer term, the industry has declined 40% in the last year. Looking forward, earnings are forecast to grow by 14% annually.

Industry Valuation and Performance

Has the U.S. Managed Healthcare Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Mon, 17 Nov 2025US$449.3bUS$974.8bUS$20.1b17.1x22.3x0.5x
Wed, 15 Oct 2025US$479.5bUS$944.0bUS$31.5b15x15.2x0.5x
Fri, 12 Sep 2025US$455.8bUS$943.9bUS$31.5b14.1x14.5x0.5x
Sun, 10 Aug 2025US$360.9bUS$943.9bUS$31.5b11.5x11.5x0.4x
Tue, 08 Jul 2025US$431.6bUS$913.9bUS$34.4b12.9x12.5x0.5x
Thu, 05 Jun 2025US$446.0bUS$913.9bUS$34.4b14x13x0.5x
Sat, 03 May 2025US$548.7bUS$913.7bUS$34.4b16.1x16x0.6x
Mon, 31 Mar 2025US$664.6bUS$887.6bUS$26.1b21.4x25.5x0.7x
Wed, 26 Feb 2025US$604.4bUS$888.1bUS$26.0b20.6x23.3x0.7x
Fri, 24 Jan 2025US$668.5bUS$882.7bUS$25.9b20.8x25.8x0.8x
Sun, 22 Dec 2024US$634.9bUS$873.5bUS$26.2b18x24.2x0.7x
Tue, 19 Nov 2024US$730.5bUS$873.5bUS$26.2b17.6x27.9x0.8x
Thu, 17 Oct 2024US$742.4bUS$864.4bUS$26.5b18.1x28x0.9x
Sat, 14 Sep 2024US$781.7bUS$855.9bUS$26.3b21.2x29.7x0.9x
Mon, 12 Aug 2024US$752.1bUS$855.8bUS$26.3b21.7x28.6x0.9x
Wed, 10 Jul 2024US$681.8bUS$844.2bUS$27.2b21.1x25x0.8x
Fri, 07 Jun 2024US$699.4bUS$844.2bUS$27.2b20.8x25.7x0.8x
Sun, 05 May 2024US$685.5bUS$844.1bUS$27.1b19.5x25.2x0.8x
Tue, 02 Apr 2024US$696.6bUS$829.6bUS$34.4b20.1x20.2x0.8x
Thu, 29 Feb 2024US$716.0bUS$832.7bUS$33.3b20.1x21.5x0.9x
Sat, 27 Jan 2024US$684.5bUS$830.1bUS$32.9b19.9x20.8x0.8x
Mon, 25 Dec 2023US$718.2bUS$809.0bUS$33.9b20.7x21.2x0.9x
Wed, 22 Nov 2023US$736.1bUS$809.0bUS$33.9b21.3x21.7x0.9x
Fri, 20 Oct 2023US$736.8bUS$803.8bUS$34.4b21.2x21.4x0.9x
Sun, 17 Sep 2023US$680.0bUS$789.4bUS$34.2b21.1x19.9x0.9x
Tue, 15 Aug 2023US$712.5bUS$789.4bUS$34.2b20.3x20.8x0.9x
Thu, 13 Jul 2023US$634.5bUS$767.3bUS$31.9b20.3x19.9x0.8x
Sat, 10 Jun 2023US$700.8bUS$767.3bUS$31.9b22.2x21.9x0.9x
Mon, 08 May 2023US$701.7bUS$767.6bUS$31.9b22.2x22x0.9x
Wed, 05 Apr 2023US$696.5bUS$747.4bUS$30.5b22.4x22.9x0.9x
Fri, 03 Mar 2023US$683.7bUS$747.4bUS$30.4b22.1x22.5x0.9x
Sun, 29 Jan 2023US$704.0bUS$741.8bUS$31.2b21.2x22.6x0.9x
Tue, 27 Dec 2022US$760.8bUS$729.4bUS$30.7b23.2x24.8x1x
Thu, 24 Nov 2022US$761.5bUS$729.4bUS$30.7b23.5x24.8x1x
Price to Earnings Ratio

24.8x


Total Market Cap: US$761.5bTotal Earnings: US$30.7bTotal Revenue: US$729.4bTotal Market Cap vs Earnings and Revenue0%0%0%
U.S. Managed Healthcare Industry Price to Earnings3Y Average 22x202320242025
Current Industry PE
  • Investors are relatively neutral on the American Managed Healthcare industry at the moment, indicating that they anticipate long term growth rates to remain steady.
  • The industry is trading close to its 3-year average PE ratio of 22.0x.
  • The industry is trading close to its 3-year average PS ratio of 0.80x.
Past Earnings Growth
  • The earnings for companies in the Managed Healthcare industry have declined 13% per year over the last three years.
  • Meanwhile revenues for these companies have grown 10% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Comparison

How does U.S. Managed Healthcare compare with similar industries?

US Market-0.39%
Healthcare3.77%
Healthcare Services-0.85%
Managed Healthcare-0.61%
Healthcare Distributors0.069%
Healthcare Services-0.34%
Healthcare Facilities-5.43%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
ELV Elevance HealthUS$325.837.3%
+US$4.9b		-18.7%PE13.1x
CNC CenteneUS$36.386.2%
+US$1.0b		-38.2%PS0.1x
UNH UnitedHealth GroupUS$321.860.09%
+US$253.6m		-45.4%PE16.6x
HQY HealthEquityUS$101.771.9%
+US$167.1m		-0.6%PE60.1x
PGNY ProgynyUS$24.553.9%
+US$80.2m		76.6%PE37.4x

Latest News

HUM
US$237.12
Humana
7D
-0.5%
1Y
-12.6%

HUM: Confidence Will Increase As Medicare Advantage Star Ratings Recover

Humana's analyst price target has been revised lower by approximately $7 to $288.46. Analysts cite a more cautious outlook on margins and an uneven recovery in Medicare Advantage profitability.
ELV
US$325.83
Elevance Health
7D
7.3%
1Y
-18.7%

ELV: Margin Recovery In Government Plans Will Drive Long-Term Upside

Analysts have modestly lowered their price target for Elevance Health, reflecting a shift from $389 to $386. This adjustment takes into account ongoing headwinds related to regulatory-driven membership changes and anticipated pressure in government-sponsored business lines.
ALHC
US$16.52
Alignment Healthcare
7D
0.9%
1Y
48.0%

ALHC: Value-Based Medicare Advantage Will Drive Market Share Gains

Analysts have raised their price target for Alignment Healthcare by $0.42 to $20.88. They cite expectations of continued revenue growth and the company's value-based Medicare Advantage model as factors supporting ongoing market share gains.
PGNY
US$24.55
Progyny
7D
3.9%
1Y
76.6%
CLOV
US$2.47
Clover Health Investments
7D
-5.0%
1Y
-23.1%

CLOV: Insurance Revenue Outlook And Care Coordination Will Drive Share Gains

Analysts have revised their price target for Clover Health Investments downward from $3.37 to $3.23 per share, citing updated financial projections as well as a moderated outlook on profit margins and growth rates. What's in the News Clover Health Investments raised its full-year 2025 earnings guidance, now projecting insurance revenue of $1.850 billion to $1.880 billion.
UNH
US$321.86
UnitedHealth Group
7D
0.09%
1Y
-45.4%
CNC
US$36.38
Centene
7D
6.2%
1Y
-38.2%
HQY
US$101.77
HealthEquity
7D
1.9%
1Y
-0.6%
MOH
US$137.54
Molina Healthcare
7D
-2.4%
1Y
-52.9%

MOH: Margin Recovery Will Rely On Navigating Medicaid Headwinds And ACA Premium Hikes

Molina Healthcare's analyst price target has been revised downward from approximately $198 to $179 per share. Analysts cite lower earnings forecasts and ongoing uncertainty in Medicaid and state-level healthcare funding as key drivers of the adjustment.